Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP5_Moderate
The NM_213622.4(STAMBP):c.299T>A(p.Phe100Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,880 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
STAMBP (HGNC:16950): (STAM binding protein) Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
In a region_of_interest Interaction with CHMP3 (size 126) in uniprot entity STABP_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_213622.4
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-73845186-T-A is Pathogenic according to our data. Variant chr2-73845186-T-A is described in ClinVar as [Pathogenic]. Clinvar id is 50796.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr2-73845186-T-A is described in Lovd as [Likely_pathogenic].
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This variant has been previously reported as disease-causing and was found once in our laboratory in trans with a nonsense variant [D252X] in a 1-month-old male with hypotonia, spasticity, seizures, microcephaly, infarction of left hemisphere globus pallidus and dural venous sinus thrombosis, bradycaridia, hypoplastic nail, rash, and mild thrombocytopenia -
Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);Loss of methylation at K102 (P = 0.0634);